Category: Drug Discovery
Global Drug Discovery
-
Global Attention Deficit Hyperactivity Disorder Databank Market Report
... 7.15% from 2021 to 2029. Stimulants segment is expected to be the highest contributor to this market, with $350.6 Million in 2020, and is anticipated to reach $669.0 Million by 2029, registering a CAGR of ... Read More
-
Global Scleroderma Therapeutics Databank Market Report
... 2031. Immunosuppressors segment is expected to be the highest contributor to this market, with $1,235.9 Million in 2022, and is anticipated to reach $1,832.6 Million by 2031, registering a CAGR of 4.52%. Prostacyclin Analogues segment ... Read More
-
Global Viral Conjunctivitis Pipeline Drugs Databank Market Report
... 3.20% from 2023 to 2031. DST-100 segment is expected to be the highest contributor to this market, with $2,017.3 Million in 2022, and is anticipated to reach $2,548.2 Million by 2031, registering a CAGR of ... Read More
-
Global Ophthalmology Drugs Databank Market Report
... 2031. Anti-VEGF Agents segment is expected to be the highest contributor to this market, with $14,005.3 Million in 2022, and is anticipated to reach $23,509.4 Million by 2031, registering a CAGR of 5.97%. Antiallergy segment ... Read More
-
Global Drugs for Malaria Market Size, Manufacturers, Opportunities and Forecast to 2030
... in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria ... Read More
-
Global Investigational Drug CDMO Databank Market Report.pdf
... from 2023 to 2031. Sclerotherapy segment is expected to be the highest contributor to this market, with $1,010.7 Million in 2022, and is anticipated to reach $1,616.5 Million by 2031, registering a CAGR of 5.40%. ... Read More
-
Global Acute Myeloid Leukemia Therapeutics Databank Market Report
... 5.19% from 2023 to 2031. Targeted Therapy and Immunotherapy segment is expected to be the highest contributor to this market, with $5,909.9 Million in 2022, and is anticipated to reach $8,938.5 Million by 2031, registering ... Read More
-
Global Insomnia Therapeutics Databank Market Report
... 2031. Drugs segment is expected to be the highest contributor to this market, with $3,103.4 Million in 2022, and is anticipated to reach $4,664.6 Million by 2031, registering a CAGR of 4.67%. Medical Devices segment ... Read More
-
Global Multiple Sclerosis Therapeutics Databank Market Report
... 2021 to 2029. Small-molecule Drugs segment is expected to be the highest contributor to this market, with $6,472.6 Million in 2020, and is anticipated to reach $12,240.1 Million by 2029, registering a CAGR of 7.38%. ... Read More
-
Global Myelodysplastic Syndrome Drugs Databank Market Report
... 2023 to 2031. Immunomodulatory Drugs segment is expected to be the highest contributor to this market, with $982.9 Million in 2022, and is anticipated to reach $2,003.9 Million by 2031, registering a CAGR of 8.28%. ... Read More
-
Global Investigational Drug CDMO Databank Market Report
... 2023 to 2031. Small Molecule segment is expected to be the highest contributor to this market, with $3,991.1 Million in 2022, and is anticipated to reach $6,166.8 Million by 2031, registering a CAGR of 5.00%. ... Read More
-
Global Liver Cancer Drugs Databank Market Report
... 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $1,442.5 Million in 2022, and is anticipated to reach $4,029.6 Million by 2031, registering a CAGR of 12.16%. ... Read More
-
Global Myeloproliferative Disorders Drugs Databank Market Report
... 2023 to 2031. Ph+ CML segment is expected to be the highest contributor to this market, with $6,196.2 Million in 2022, and is anticipated to reach $7,194.7 Million by 2031, registering a CAGR of 1.71%. ... Read More
-
Global Idiopathic Pulmonary Fibrosis Treatment Databank Market Report
... 10.94% from 2021 to 2029. MAPK Inhibitors segment is expected to be the highest contributor to this market, with $1,304.4 Million in 2020, and is anticipated to reach $3,116.3 Million by 2029, registering a CAGR ... Read More
-
Global Celiac Disease Drug Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Celiac Disease Drug industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Celiac Disease Drug. The report also introduces players ... Read More
-
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
... qualitative data, to help readers develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding exosome products. BCC Research estimates market data for 2022 (the ... Read More
-
Global Oligonucleotide Therapeutics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Ebola Virus Infection Market - 2024-2031
... the forecast period 2024-2031. Ebola virus disease formerly known as ebola haemorrhagic fever is a severe often fatal illness affecting humans and other primates. The virus is transmitted to people from wild animals such as ... Read More
-
Neurological Disorder Drugs Market Size, Trends, Analysis, and Outlook By Disorder (Epilepsy, Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Cerebrovascular Disease, Others), By Drug (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Antiepileptic, Antipsychotic and Antidepressant, Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032
... Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), by Country, Segment, and Companies, 2024-2032 The global Neurological Disorder Drugs market size is poised to register 5.2% growth from 2024 to 2032, presenting significant growth prospects for ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics Market Size, Trends, Analysis, and Outlook By Therapeutics (Marketed Drugs, Pipeline Drugs), By Diagnostics (Lumbar Puncture Test, Computed Tomography Scan, Magnetic Resonance Imaging, Electroencephalography, Positron Emission Tomography Scan, Others), by Country, Segment, and Companies, 2024-2032
... Country, Segment, and Companies, 2024-2032 The global Alzheimer's Disease Diagnostics and Therapeutics market size is poised to register 5.8% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The ... Read More
-
Global Hyperkalemia Drugs Market - 2024-2031
... period 2024-2031. Hyperkalemia is a condition with too much potassium in the blood above the average level. Hyperkalemia happens if the kidneys do not work well which leads to life-threatening heart rhythm changes or cardiac ... Read More
-
Me Too Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Beta Blockers, Antidepressants, Statins, Proton Pump Inhibitors, Benzodiazepines, Others), By Therapeutic Area (Oncology, Diabetes, Hepatitis C, Cardiovascular, Others), By Region and Competition, 2019-2029F
... By Region and Competition, 2019-2029F Global Me Too Drugs Market was valued at USD 364.81 Million in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.87% through ... Read More
-
Anti-obesity Drugs Market Report 2024-2034
... dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increased Prevalence of Obesity Over the past few decades, obesity ... Read More
-
Gaucher Disease Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2024-2032
... The global Gaucher disease market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032. ... Read More
-
Global AI in Drug Discovery Market 2024
... and predictive analytics, pharmaceutical companies can expedite the discovery of innovative therapeutics, improve patient outcomes, and address unmet medical needs more effectively. The global AI in drug discovery market was valued at USD 991.2 million ... Read More
Research Assistance
